The role of the CXCL12/CXCR4/CXCR7 chemokine axis in cancer

Y Shi, DJ Riese, J Shen - Frontiers in pharmacology, 2020 - frontiersin.org
Chemokines are a family of small, secreted cytokines which regulate a variety of cell
functions. The CXC motif chemokine ligand 12 (CXCL12) binds to CXC chemokine receptor …

Chemokines and chemokine receptors: new targets for cancer immunotherapy

V Mollica Poeta, M Massara, A Capucetti… - Frontiers in …, 2019 - frontiersin.org
Immunotherapy is a clinically validated treatment for many cancers to boost the immune
system against tumor growth and dissemination. Several strategies are used to harness …

Chemokine-directed tumor microenvironment modulation in cancer immunotherapy

P Bule, SI Aguiar, F Aires-Da-Silva… - International journal of …, 2021 - mdpi.com
Chemokines are a large family of small chemotactic cytokines that coordinates immune cell
trafficking. In cancer, they have a pivotal role in the migration pattern of immune cells into the …

Immunomodulatory mechanisms and therapeutic potential of mesenchymal stem cells

G Yang, X Fan, Y Liu, P Jie, M Mazhar, Y Liu… - Stem Cell Reviews and …, 2023 - Springer
Mesenchymal stem cells (MSCs) are regarded as highly promising cells for allogeneic cell
therapy, owing to their multipotent nature and ability to display potent and varied functions in …

[HTML][HTML] Dual blockade of CXCL12-CXCR4 and PD-1–PD-L1 pathways prolongs survival of ovarian tumor–bearing mice by prevention of immunosuppression in the …

Y Zeng, B Li, Y Liang, PM Reeves, X Qu, C Ran… - The FASEB …, 2019 - ncbi.nlm.nih.gov
Blockade of immune-checkpoint programmed cell death protein 1 (PD-1) or programmed
cell death ligand 1 can enhance effector T-cell responses. However, the lack of response in …

CXCR4 and CXCR7 signaling pathways: a focus on the cross-talk between cancer cells and tumor microenvironment

S Santagata, C Ieranò, AM Trotta, A Capiluongo… - Frontiers in …, 2021 - frontiersin.org
The chemokine receptor 4 (CXCR4) and 7 (CXCR7) are G-protein-coupled receptors
(GPCRs) activated through their shared ligand CXCL12 in multiple human cancers. They …

CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent

J Wang, BA Tannous, MC Poznansky, H Chen - Pharmacological research, 2020 - Elsevier
Abstract AMD3100 (plerixafor), a CXCR4 antagonist, has opened a variety of avenues for
potential therapeutic approaches in different refractory diseases. The CXCL12/CXCR4 axis …

Recent advances in CXCL12/CXCR4 antagonists and nano-based drug delivery systems for cancer therapy

R Zhao, J Liu, Z Li, W Zhang, F Wang, B Zhang - Pharmaceutics, 2022 - mdpi.com
Chemokines can induce chemotactic cell migration by interacting with G protein-coupled
receptors to play a significant regulatory role in the development of cancer. CXC chemokine …

CXCL12 signaling in the tumor microenvironment

L Portella, AM Bello, S Scala - … : The Role of Chemokines–Part B, 2021 - Springer
Tumor microenvironment (TME) is the local environment of tumor, composed of tumor cells
and blood vessels, extracellular matrix (ECM), immune cells, and metabolic and signaling …

Polyfunctionality of the CXCR4/CXCL12 axis in health and disease: Implications for therapeutic interventions in cancer and immune‐mediated diseases

C Britton, MC Poznansky, P Reeves - The FASEB Journal, 2021 - Wiley Online Library
Historically the chemokine receptor CXCR4 and its canonical ligand CXCL12 are
associated with the bone marrow niche and hematopoiesis. However, CXCL12 exhibits …